Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2019 Jun 3:cebp.0145.2019. doi: 10.1158/1055-9965.EPI-19-0145

Table 2.

Geometric Mean Serum PSA Concentration (ng/mL) and 95% CIs by Quintile of Fibrosis Scores Among Men 40 Years and Older, NHANES 2001–2010

APRI
Q1 (<0.24) Q2 (0.24 to <0.29) Q3 (0.29 to <0.35) Q4 (0.35 to <0.44) Q5 (≥0.44) Per 1 unit increase in fibrosis score
(p trend)
Model 1a 1.03 (0.98,1.09) 0.96 (0.91,1.02) 0.94 (0.89,0.99) 0.97 (0.93,1.01) 0.89 (0.84,0.95) −0.36 (<0.001)
Model 2b 1.04 (0.99,1.10) 0.96 (0.91,1.02) 0.93 (0.89,0.98) 0.97 (0.93,1.01) 0.89 (0.84,0.95) −0.38 (<0.001)
FIB4
Q1 (<0.79) Q2 (0.79 to <0.99) Q3 (0.99 to <1.23) Q4 (1.23 to <1.62) Q5 (≥1.62) Per 1 unit increase in fibrosis score
(p trend)
Model 1 1.03 (0.97,1.08) 0.96 (0.92,1.01) 0.97 (0.91,1.03) 0.94 (0.89,0.99) 0.90 (0.84,0.96) −0.09 (0.007)
Model 2 1.04 (0.99,1.10) 0.97 (0.93,1.02) 0.97 (0.92,1.03) 0.94 (0.89,0.99) 0.88 (0.83,0.95) −0.11 (0.001)
NFS
Q1 (<0.17) Q2 (0.17 to <0.89) Q3 (0.89 to <1.58) Q4 (1.58 to <2.42) Q5 (≥2.42) Per 1 unit increase in fibrosis score
(p trend)
Model 1 1.05 (1.00,1.11) 0.99 (0.94,1.04) 1.01 (0.96,1.05) 0.92 (0.86,0.98) 0.84 (0.78,0.91) −0.06 (<0.001)
Model 2 1.02 (0.96,1.08) 0.96 (0.92,1.01) 1.00 (0.95,1.04) 0.93 (0.87,0.99) 0.89 (0.82,0.96) −0.04 (0.017)
a

Model 1 adjusted for age and race;

b

Model 2 adjusted for the age, race, BMI category, diabetes status, alcohol drinking status and smoking status.